Benazepril: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Amr Marawan (talk | contribs) No edit summary |
||
| Line 36: | Line 36: | ||
| [[File:Los-w.png|800px|thumb]] | | [[File:Los-w.png|800px|thumb]] | ||
|} | |} | ||
==Interactions with Alcohol== | |||
[[Category:Cardiovascular Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 17:40, 14 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2]
For patient information about Benazepril, click here.
Synonyms / Brand Names: LOTENSIN®
Overview
Benazepril, brand name Lotensin (Novartis), is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor.
Category
Antihypertensive Agents, ACE Inhibitors
FDA Package Insert
LOTENSIN (benazepril hydrochloride) tablet
Indications and Usage | Dosage and Administration | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Description | Clinical Pharmacology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
 |